Literature DB >> 15269943

A comparison of images generated from diffusion-weighted and diffusion-tensor imaging data in hyper-acute stroke.

Ashley D Harris1, Raoul S Pereira, J Ross Mitchell, Michael D Hill, Robert J Sevick, Richard Frayne.   

Abstract

PURPOSE: To compare isotropic (combined diffusion-weighted image [CMB], apparent diffusion coefficient [ADC], TRACE, exponential ADC [eADC], and isotropically-weighted diffusion image [isoDWI]) and anisotropic (relative anisotropy [RA], fractional anisotropy [FA], and volume ratio [VR]) diffusion images collected with fast magnetic resonance (MR) diffusion-weighted (DWI) and diffusion-tensor (DTI) acquisition strategies (each less than one minute) in hyper-acute stroke.
MATERIALS AND METHODS: Twenty-one patients suffering from ischemic stroke-imaged within six hours of symptom onset using both DWI and DTI-were analyzed. Regions of interest were placed in the ischemic lesion and in normal contralateral tissue and the percent difference in image intensity was calculated for all nine generated images.
RESULTS: The average absolute percent changes for the isotropic strategies were all > 38%, with isoDWI found to have a difference of 50.7% +/- 7.9% (mean +/- standard error, P < 0.001). The ADC maps had the most significant difference (-42.4% +/- 2.0%, P < 0.001, coefficient of variation = 0.22). No anisotropic images had significant differences.
CONCLUSION: Anisotropic maps do not consistently show changes in the first six hours of ischemic stroke; therefore, isotropic maps, such as those obtained using DWI, are more appropriate for detecting hyper-acute stroke. Anisotropic images, however, may be useful to differentiate hyper-acute stroke from acute and sub-acute stroke. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15269943     DOI: 10.1002/jmri.20116

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  7 in total

Review 1.  Neuroimaging of ischemia and infarction.

Authors:  Erica C Sá de Camargo; Walter J Koroshetz
Journal:  NeuroRx       Date:  2005-04

2.  Decreased fractional anisotropy of middle cerebellar peduncle in crossed cerebellar diaschisis: diffusion-tensor imaging-positron-emission tomography correlation study.

Authors:  Jinna Kim; Seung-Koo Lee; Jong Doo Lee; Yong Wook Kim; Dong Ik Kim
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

3.  Use of diffusion tensor imaging to identify similarities and differences between cerebellar and Parkinsonism forms of multiple system atrophy.

Authors:  Po-Shan Wang; Hsiu-Mei Wu; Ching-Po Lin; Bing-Wen Soong
Journal:  Neuroradiology       Date:  2010-08-25       Impact factor: 2.804

Review 4.  Use of perfusion imaging and other imaging techniques to assess risks/benefits of acute stroke interventions.

Authors:  Jason Tarpley; Dan Franc; Aaron P Tansy; David S Liebeskind
Journal:  Curr Atheroscler Rep       Date:  2013-07       Impact factor: 5.113

5.  Time course of axial and radial diffusion kurtosis of white matter infarctions: period of pseudonormalization.

Authors:  T Taoka; M Fujioka; M Sakamoto; T Miyasaka; T Akashi; T Ochi; S Hori; M Uchikoshi; J Xu; K Kichikawa
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-03       Impact factor: 3.825

6.  Comprehensive analysis of early fractional anisotropy changes in acute ischemic stroke.

Authors:  Anna Christina Alegiani; Simon MacLean; Hanna Braass; Susanne Siemonsen; Christian Gerloff; Jens Fiehler; Tae-Hee Cho; Laurent Derex; Marc Hermier; Yves Berthezene; Norbert Nighoghossian; Götz Thomalla
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

7.  Diffusion Tensor-Derived Properties of Benign Oligemia, True "at Risk" Penumbra, and Infarct Core during the First Three Hours of Stroke Onset: A Rat Model.

Authors:  Fang-Ying Chiu; Duen-Pang Kuo; Yung-Chieh Chen; Yu-Chieh Kao; Hsiao-Wen Chung; Cheng-Yu Chen
Journal:  Korean J Radiol       Date:  2018-10-18       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.